NEA Management Company, LLC

Q2 2025 13F Holdings

  • Location
    timonium, MD
  • Num holdings

    32

  • Value ($000)

    $1,328,451

  • Date Filed
    08/14/2025
  • Form type
    13F-HR
  • CIK
    0001512848
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
ACLX
ACLX

ARCELLX INC

COMMON STOCK
03940C100
$246.63M
19 %

3,745,262

VRNA
VRNA

VERONA PHARMA PLC

SPONSERED ADS
925050106
$214.05M
16 %

2,263,138

RYTM
RYTM

RHYTHM PHARMACEUTICALS INC

COM
76243J105
$183.88M
14 %

2,909,956

COUR
COUR

COURSERA INC

COM
22266M104
$112.72M
9 %

12,867,769

---

CRISPR THERAPEUTICS AG

NAMEN AKT
H17182108
$77.23M
6 %

1,587,854

---

TREVI THERAPEUTICS INC

COM
89532M101
$72.33M
5 %

13,222,228

YB4P
YB4P

SAVARA INC

COM
805111101
$55.79M
4 %

24,471,264

ORIC
ORIC

ORIC PHARMACEUTICALS INC

COM
68622P109
$41.80M
3 %

4,118,621

---

MBX BIOSCIENCES INC

COM
55287L101
$41.24M
3 %

3,614,486

GLUE
GLUE

MONTE ROSA THERAPEUTICS INC

COM
61225M102
$34.69M
3 %

7,692,298

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 32